CINECA IRIS Institutional Research Information System

TORREGROSSA, LIBORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.933
AS - Asia 3.792
EU - Europa 3.717
SA - Sud America 706
AF - Africa 342
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 16.501
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.738
IT - Italia 1.207
SG - Singapore 1.184
CN - Cina 1.090
HK - Hong Kong 722
DE - Germania 632
BR - Brasile 606
SE - Svezia 556
AT - Austria 295
GB - Regno Unito 259
VN - Vietnam 209
BG - Bulgaria 202
CI - Costa d'Avorio 164
FI - Finlandia 129
TR - Turchia 129
RU - Federazione Russa 119
IN - India 118
CA - Canada 115
FR - Francia 88
SN - Senegal 77
JP - Giappone 64
KR - Corea 52
PL - Polonia 42
BD - Bangladesh 39
AR - Argentina 37
MX - Messico 36
IQ - Iraq 31
NL - Olanda 31
ZA - Sudafrica 28
UA - Ucraina 27
SA - Arabia Saudita 26
NG - Nigeria 25
ES - Italia 24
PK - Pakistan 23
MA - Marocco 22
EC - Ecuador 18
CZ - Repubblica Ceca 16
BE - Belgio 13
EE - Estonia 13
ID - Indonesia 13
LT - Lituania 13
IR - Iran 12
CO - Colombia 11
JO - Giordania 11
UZ - Uzbekistan 11
CH - Svizzera 10
NP - Nepal 10
VE - Venezuela 10
GR - Grecia 8
IE - Irlanda 8
KE - Kenya 8
PY - Paraguay 8
DO - Repubblica Dominicana 7
EU - Europa 6
PA - Panama 6
PE - Perù 6
TW - Taiwan 6
AL - Albania 5
AU - Australia 5
AZ - Azerbaigian 5
CL - Cile 5
EG - Egitto 5
HN - Honduras 5
HU - Ungheria 5
JM - Giamaica 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
IL - Israele 4
PH - Filippine 4
CY - Cipro 3
DZ - Algeria 3
GD - Grenada 3
GT - Guatemala 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MY - Malesia 3
OM - Oman 3
PS - Palestinian Territory 3
UY - Uruguay 3
BY - Bielorussia 2
DK - Danimarca 2
GA - Gabon 2
LB - Libano 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
RS - Serbia 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
Totale 16.488
Salva come PNG Salva come JPEG
Città #
Dallas 1.125
Ashburn 1.001
Hong Kong 715
Singapore 687
Chandler 649
Fairfield 566
Santa Clara 528
Woodbridge 384
Shanghai 282
Houston 281
Milan 272
Seattle 270
Vienna 263
New York 243
Beijing 230
Ann Arbor 218
Sofia 202
Wilmington 200
Cambridge 199
Los Angeles 177
Abidjan 164
Boardman 147
Munich 141
Pisa 133
Serra 119
Florence 118
Princeton 117
Lawrence 96
Medford 82
London 78
Dakar 77
Frankfurt am Main 77
Hefei 72
Turku 65
Ottawa 60
Rome 56
Istanbul 55
Tokyo 53
San Diego 52
São Paulo 52
Ho Chi Minh City 50
Seoul 46
Redondo Beach 45
Buffalo 42
Bremen 39
Cascina 37
Nanjing 33
Izmir 32
Dong Ket 31
Des Moines 30
Hanoi 30
Ogden 29
Vicopisano 28
Warsaw 26
Helsinki 24
Poplar 24
Redmond 24
Belo Horizonte 22
Lagos 22
Chicago 21
Düsseldorf 21
Boulder 20
Johannesburg 20
Rio de Janeiro 20
Nuremberg 19
Phoenix 19
Fuzhou 18
Montreal 18
Hyderabad 17
Lancaster 17
Lucca 17
Brasília 16
Brooklyn 16
Quanzhou 16
Dearborn 15
Guangzhou 15
Ankara 14
Atlanta 14
Norwalk 14
Council Bluffs 13
Denver 13
Manchester 13
Naples 13
Toronto 13
Zhengzhou 13
Brussels 12
Casablanca 12
Orem 12
Stockholm 12
Washington 12
Amman 11
Baghdad 11
Boston 11
Changsha 11
Jacksonville 11
Kent 11
Shenyang 11
Tashkent 11
Brno 10
Mexico City 10
Totale 11.513
Salva come PNG Salva come JPEG
Nome #
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 233
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 220
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 218
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 217
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 205
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 204
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 204
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 203
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 202
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 195
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 186
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 184
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 180
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 170
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 167
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 166
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 165
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 163
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 163
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 162
null 160
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 160
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 160
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 159
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 158
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 158
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 157
5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I 156
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 156
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 155
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 155
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 153
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 153
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 152
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study 152
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 151
Exome analysis of a large family with Familial Isolated Primary Hyperparathyroidism (FIHP) and multiple cancers. 149
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 149
Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma 149
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer 148
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas 148
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 148
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. 147
DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions 147
Impact of energy-based devices in pediatric thyroid surgery 147
Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonance-based study 146
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 146
A large functioning parathyroid lipoadenoma 145
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 144
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 142
Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. 142
Digital Gene Expression Analysis on Cytology Smears Can Rule Out Malignancy in Follicular-Patterned Thyroid Tumors 142
Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations 142
Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism 141
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19 140
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 138
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience 137
COVID-19 autopsy cases: detection of virus in endocrine tissues 137
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases 134
Toward the Reliable Diagnosis of Indeterminate Thyroid Lesions: A HRMAS NMR-Based Metabolomics Case of Study 133
5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I 133
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas. 132
Expression of duox1 in papillary thyroid cancer and in normal thyroid tissues and correlation with ret/ptc rearrangements 132
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 132
Do Patients with Atypical Parathyroid Adenoma Need Close Follow-up? 132
In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features 131
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 131
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 129
Human papillomavirus-related head and neck adenosquamous carcinoma: A systematic review and individual patient data meta-analysis 129
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center 129
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses 129
Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience 128
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. 128
Anaplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies 128
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 127
An adrenal cortical adenoma with neuroendocrine-type granules mimicking pheochromocytoma 125
High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: a preliminary experience 125
Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity 124
CXC Chemokine Receptor 4 Immunodetection in the Follicular Variant of Papillary Thyroid Carcinoma: Comparison to Galectin-3 and Hector Battifora Mesothelial Cell-1 122
Gene expression profile in metastatic and non-metastatic parathyroid carcinoma 122
Galectin-3 is highly expressed in nonencapsutated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothetial cell 1 immunoreactivity 118
Radioiodine remnant ablation (RRA) Impact on the dynamic risk of restratification in the short-term follow-up of patients with differentiated thyroid cancer (DTC). 118
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis 116
A Case of Unilateral Dermopathy Possibly Related to Graves' Disease 115
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 110
Correlation of the presurgical diagnosis of follicular variant of papillary thyroid cancer with the disease status after 10 years of follow-up. 109
Ret mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 108
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 105
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 105
First report of benign track seeding after robot-assisted transaxillary thyroid surgery 105
Atypical parathyroid adenomas: Challenging lesions in the differential diagnosis of endocrine tumors 105
The Integrity of Tumor Capsule Identifies a Subgroup of Indolent Cases Not Only Among the Follicular (FVPTC) But Also in Classic Variant of Papillary Thyroid Cancer (CVPTC) 102
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer 102
Follicular (FVPTC) VS Classical (CVPTC) variant of papillary thyroid cancer: correlation of the outcome after 12 years of follow up. 101
Firm mass in thyroid of an elderly patient: Not always cancer 101
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 99
Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4) 98
Molecular genetics of follicular-derived thyroid cancer 98
Hippo pathway affects survival of cancer patients: Extensive analysis of TCGA data and review of literature 97
MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions 95
Totale 14.418
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.953
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021542 0 0 0 0 0 76 70 60 85 67 77 107
2021/20221.189 27 24 41 47 195 222 55 42 72 62 103 299
2022/20232.332 221 343 194 198 248 253 29 185 464 11 152 34
2023/20241.465 117 130 191 168 175 260 73 35 29 39 107 141
2024/20254.521 46 143 59 257 446 443 369 203 454 519 493 1.089
2025/20263.782 437 882 937 694 690 142 0 0 0 0 0 0
Totale 16.850